Product Information
CLOTRIMAZOLE 10 MG LOZENGE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2872 per EA under NDC 16571068607. Its NADAC has been published 91 times since Oct 2, 2024.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571068607
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA215641On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE 10 MG LOZENGE has been published 91 times since Oct 2, 2024, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2872 per EA |
|---|---|
| All-time high | $0.3922 (Oct 16, 2024) |
| All-time low | $0.2871 (May 20, 2026) |
| 52-week high | $0.3580 |
| 52-week low | $0.2871 |
| Median price | $0.3513 |
| Average price | $0.3387 |
| Largest weekly change | -7.2% (Nov 20, 2024) |
| Weeks tracked | 91 |
| Tracking since | Oct 2, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE 10 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE 10 MG LOZENGE, manufactured by Rising Pharma Holdings Inc., is $0.2872 per EA (NDC 16571068607), effective Jun 24, 2026.
How has the price of CLOTRIMAZOLE 10 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE 10 MG LOZENGE has declined 26.8%. It has been tracked across 91 weekly CMS publications since Oct 2, 2024.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE 10 MG LOZENGE?
Since Oct 2, 2024, the NADAC for CLOTRIMAZOLE 10 MG LOZENGE has ranged from a low of $0.2871 (May 20, 2026) to a high of $0.3922 (Oct 16, 2024), with a median of $0.3513 per EA.
Are there cheaper alternatives to CLOTRIMAZOLE 10 MG LOZENGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CLOTRIMAZOLE 10 MG LOZENGE, but none are currently priced below it.
Who manufactures CLOTRIMAZOLE 10 MG LOZENGE?
CLOTRIMAZOLE 10 MG LOZENGE (NDC 16571068607) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification